IL152154A0 - Sulfonamide-derivatives - Google Patents

Sulfonamide-derivatives

Info

Publication number
IL152154A0
IL152154A0 IL15215401A IL15215401A IL152154A0 IL 152154 A0 IL152154 A0 IL 152154A0 IL 15215401 A IL15215401 A IL 15215401A IL 15215401 A IL15215401 A IL 15215401A IL 152154 A0 IL152154 A0 IL 152154A0
Authority
IL
Israel
Prior art keywords
sulfonamide
derivatives
Prior art date
Application number
IL15215401A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL152154A0 publication Critical patent/IL152154A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15215401A 2000-05-19 2001-05-04 Sulfonamide-derivatives IL152154A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582200P 2000-05-19 2000-05-19
PCT/US2001/011746 WO2001090056A1 (en) 2000-05-19 2001-05-04 Sulfonamide derivatives

Publications (1)

Publication Number Publication Date
IL152154A0 true IL152154A0 (en) 2003-05-29

Family

ID=22763775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15215401A IL152154A0 (en) 2000-05-19 2001-05-04 Sulfonamide-derivatives

Country Status (25)

Country Link
US (2) US6720357B2 (ru)
EP (1) EP1296944A1 (ru)
JP (1) JP2003534315A (ru)
KR (1) KR20030007643A (ru)
CN (1) CN1429206A (ru)
AR (1) AR028590A1 (ru)
AU (1) AU2001262936A1 (ru)
BR (1) BR0110871A (ru)
CA (1) CA2409829A1 (ru)
CZ (1) CZ20023796A3 (ru)
DZ (1) DZ3344A1 (ru)
EA (1) EA004868B1 (ru)
EC (1) ECSP014079A (ru)
HR (1) HRP20020917A2 (ru)
HU (1) HUP0302291A3 (ru)
IL (1) IL152154A0 (ru)
MX (1) MXPA02010021A (ru)
NO (1) NO20025533L (ru)
NZ (1) NZ521620A (ru)
PE (1) PE20011260A1 (ru)
PL (1) PL358184A1 (ru)
SK (1) SK16322002A3 (ru)
SV (1) SV2002000458A (ru)
WO (1) WO2001090056A1 (ru)
ZA (1) ZA200208746B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (ru) * 1996-12-20 2003-09-15 Пфайзер, Інк. Предотвращение потери костной массы и ее восстановление с помощью агонистов простагландина
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US20040235957A1 (en) * 2001-10-12 2004-11-25 David Bleakman Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
CN1956949A (zh) * 2003-09-18 2007-05-02 默克公司 取代的磺酰胺
MX2011013884A (es) 2009-06-26 2012-02-01 Pfizer Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas.
KR101569842B1 (ko) 2009-09-30 2015-11-17 삼성전자 주식회사 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
BR112015031249A2 (pt) 2013-06-13 2017-07-25 Veroscience Llc método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea
WO2000006537A1 (en) 1998-07-31 2000-02-10 Eli Lilly And Company N-substituted sulfonamide derivatives
PE20000943A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de sulfonamida
AU5239999A (en) 1998-07-31 2000-02-21 Eli Lilly And Company Heterocyclyl sulphonamide derivatives

Also Published As

Publication number Publication date
US6720357B2 (en) 2004-04-13
US20030233015A1 (en) 2003-12-18
ECSP014079A (es) 2002-02-25
PE20011260A1 (es) 2001-12-11
AU2001262936A1 (en) 2001-12-03
SK16322002A3 (sk) 2003-05-02
HUP0302291A3 (en) 2006-11-28
EP1296944A1 (en) 2003-04-02
US20040143020A1 (en) 2004-07-22
NO20025533L (no) 2003-01-20
CN1429206A (zh) 2003-07-09
EA004868B1 (ru) 2004-08-26
SV2002000458A (es) 2002-10-24
ZA200208746B (en) 2004-02-10
NZ521620A (en) 2004-08-27
WO2001090056A1 (en) 2001-11-29
EA200201232A1 (ru) 2003-04-24
MXPA02010021A (es) 2003-02-12
NO20025533D0 (no) 2002-11-18
KR20030007643A (ko) 2003-01-23
DZ3344A1 (fr) 2001-11-29
US6803484B2 (en) 2004-10-12
CA2409829A1 (en) 2001-11-29
JP2003534315A (ja) 2003-11-18
BR0110871A (pt) 2003-02-11
PL358184A1 (en) 2004-08-09
HRP20020917A2 (en) 2004-02-29
CZ20023796A3 (cs) 2003-04-16
HUP0302291A2 (hu) 2003-11-28
AR028590A1 (es) 2003-05-14

Similar Documents

Publication Publication Date Title
DE60105852D1 (en) Fluidmischsystem
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60121590D1 (en) Pyrazolderivate
DE60115644D1 (en) Thiazinoxazolidinon
AU3391801A (en) Pyridinylimidazoles
DE60128102D1 (en) Imidazolderivate
DE50104081D1 (en) Hydrolager
DE50105205D1 (en) Creatinin-biosensor
DE60114954D1 (en) Polytrimethylenterephthalatgarn
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE60120222D1 (en) Laser-anemometer
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE50112014D1 (en) Stiftheizer
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50107703D1 (en) Creatininsensor-kalibration
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114303D1 (en) Nsaugluftkanal
DE60114837D1 (en) Signalmessung
IL152154A0 (en) Sulfonamide-derivatives
DE50114375D1 (en) Compound-reibungsvakuumpumpe